title: Reply to: Costa DC et al. The use of subconjunctival triamcinolone acetonide (SCTA) in the management of corneal endothelial graft rejection.
authors.forename: Y
authors.initials: Y
authors.lastname: Athanasiadis
authors.forename: D
authors.initials: D
authors.lastname: de Wit
authors.forename: V
authors.initials: V
authors.lastname: Kumar
authors.forename: John E
authors.initials: JE
authors.lastname: Moore
authors.forename: Anant
authors.initials: A
authors.lastname: Sharma
mesh_terms: D016039:Corneal Transplantation / Q000379:methods*; D005938:Glucocorticoids / Q000008:administration & dosage; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D056965:Injections, Intraocular; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014222:Triamcinolone Acetonide